Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases - Part 1

About this episode

Dr. Justin Abbatemarco and Dr. Paulus Rommer discuss the relationship between Epstein-Barr virus and multiple sclerosis in this episode.

In part one of this series, Dr. Justin Abbatemarco and Dr. Paulus Rommer discuss the relationship between Epstein-Barr virus and multiple sclerosis, as well as the questions that still remain unanswered. Show citation: Vietzen H, Kühner LM, Berger SM, et al. Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. JAMA Neurol . Published online March 9, 2026. doi: 10.1001/jamaneurol.2026.0240 Show transcript: Dr. Justin Abbatemarco: Hello and welcome. I just finished interviewing Paulus Rommer on his article published in JAMA Neurology, Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases. Paulus, could we maybe talk about this relationship that we've understood about multiple sclerosis and Epstein-Barr virus? And maybe the points that still remain unanswered? Dr. Paulus Romme: There's a very long story behind this because in 1868, Pierre Marie, a student of Charcot was talking about that multiple sclerosis is a sequelae of an infection disorder. By this, we now know that there's a long story. There have been associations between infectious mononucleosis, EBV infection, multiple…

People in this episode

Host: Dr. Justin Abbatemarco

Guest: Dr. Paulus Rommer

Topics covered

• Epstein-Barr virus
• multiple sclerosis
• neuroinflammatory diseases
• medical research
• unanswered questions

Keywords

• Epstein-Barr virus
• multiple sclerosis
• neuroinflammatory diseases
• JAMA Neurology
• medical research

Mentioned in this episode

Organizations: JAMA Neurology, American Academy of Neurology

Books & works: Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases

More episodes of Neurology Minute

• Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 2 · May 5, 2026 · 5 min
• Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases - Part 2 · May 4, 2026 · 2 min
• Clinical Reasoning Series: A 70-Year-Old Man With Systemic Illness Related Strokes Refractory to Medical Treatment Managed With Intracranial Stent · May 1, 2026 · 2 min
• Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1 · April 29, 2026 · 4 min
• April 20, 2026 Capitol Hill Report: Neuroscience Research in FY2027 · April 28, 2026 · 2 min
• Navigating the Residency Application Process: Key Takeaways for Aspiring Neurologists · April 27, 2026 · 5 min